早期非小细胞肺癌立体定向体部放疗后症状性放射性肋骨骨折
本研究回顾244例接受立体定向体部放疗的早期非小细胞肺癌病例,中位随访48个月,4年≥1级和≥2级放射性肋骨骨折累积发生率分别为26.4%和8.0%。年龄与≥2级放射性肋骨骨折相关(p=0.024),V40Gy是唯一在1级与≥2级组间有显著差异的剂量学参数(p=0.015)。V40Gy≤3.83 cc组与>3.83 cc组的4年≥2级放射性肋骨骨折发生率分别为1.8%和14.2%(p=0.001),作者推荐将V40Gy≤3.83 cc作为≥2级放射性肋骨骨折的阈值。
要点
- 4年≥1级和≥2级放射性肋骨骨折累积发生率分别为26.4%和8.0%。
- 仅年龄与≥2级放射性肋骨骨折发生相关(p=0.024)。
- V40Gy≤3.83 cc组4年≥2级放射性肋骨骨折发生率为1.8%,>3.83 cc组为14.2%(p=0.001)。
核心结论
- 作者推荐将V40Gy≤3.83 cc作为立体定向体部放疗中≥2级放射性肋骨骨折的阈值。
研究设计与样本
- 回顾性分析244例接受立体定向体部放疗的早期非小细胞肺癌病例,中位随访48个月。
- 采用Gray检验和Fine-Gray模型分析临床与剂量学因素与≥2级(即症状性)放射性肋骨骨折的关系。
- 采用Fine-Gray模型评估各剂量参数对≥1级和≥2级放射性肋骨骨折的影响,t检验比较1级与≥2级组各剂量参数,ROC曲线检验最佳阈值。
主要发现
- 4年≥1级和≥2级放射性肋骨骨折累积发生率分别为26.4%和8.0%。
- 临床因素中仅年龄与≥2级放射性肋骨骨折发生相关(p=0.024)。
- 剂量学参数中仅V40Gy在1级与≥2级组间有显著差异(p=0.015)。
- V40Gy≤3.83 cc组与>3.83 cc组的4年≥2级放射性肋骨骨折发生率分别为1.8%和14.2%(p=0.001)。
关键数值与推荐
- ≥2级放射性肋骨骨折的ROC曲线最佳诊断阈值:D3cc为45.86 Gy(AUC 0.706),D4cc为39.02 Gy(AUC 0.705),D5cc为41.62 Gy(AUC 0.702),V40Gy为3.83 cc(AUC 0.730)。
- V40Gy≤3.83 cc是≥2级放射性肋骨骨折的最佳指标。
临床怎么用
- 作者推荐将V40Gy≤3.83 cc作为立体定向体部放疗中≥2级放射性肋骨骨折的阈值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The present study investigated the relationships between the risk of radiation-induced rib fractures (RIRF) and clinical and dosimetric factors in stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer (NSCLC). We also examined dosimetric parameters associated with symptomatic or asymptomatic RIRF and the dosimetric threshold for symptomatic RIRF. MATERIALS AND METHODS: We reviewed 244 cases of early-stage NSCLC treated with SBRT. Gray's test and the Fine-Gray model were performed to examine the relationships between clinical and dosimetric factors and grade ≥ 2 (i.e., symptomatic) RIRF. The effects of each dose parameter on grade ≥ 1 and ≥ 2 RIRF were assessed with the Fine-Gray model. The t-test was used to compare each dose parameter between the grade 1 and grade ≥ 2 groups. Optimal thresholds were tested using receiver operating characteristic (ROC) curves. RESULTS: With a median follow-up period of 48 months, the 4-year cumulative incidence of grade ≥ 1 and grade ≥ 2 RIRF were 26.4 % and 8.0 %, respectively. Regarding clinical factors, only age was associated with the development of grade ≥ 2 RIRF (p = 0.024). Among dosimetric parameters, only V40Gy significantly differed between the grade 1 and grade ≥ 2 groups (p = 0.015). The ROC curve analysis of grade ≥ 2 RIRF showed that the optimal diagnostic thresholds for D3cc, D4cc, D5cc, and V40Gy were 45.86 Gy (area under the curve [AUC], 0.706), 39.02 Gy (AUC, 0.705), 41.62 Gy (AUC, 0.702), and 3.83 cc (AUC, 0.730), respectively. These results showed that V40Gy ≤ 3.83 cc was the best indicator of grade ≥ 2 RIRF. The 4-year incidence of grade ≥ 2 RIRF in the V40Gy ≤ 3.83 cc vs. > 3.83 cc groups was 1.8 % vs. 14.2 % (p = 0.001). CONCLUSION: The present results recommend V40Gy ≤ 3.83 cc as the threshold for grade ≥ 2 RIRF in SBRT.
引用
- Kita N, Tomita N, Takaoka T, et al. Symptomatic radiation-induced rib fractures after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Clin Transl Radiat Oncol. 2023. PMID: 37790583. doi:10.1016/j.ctro.2023.100683
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。